CRWV
A raise, but not exactly a love letter
CoreWeave got a little gift from Sanford C. Bernstein: a price-target hike to $67 from $56. The catch? Bernstein still stamped the stock Underperform, which is analyst-speak for “nice try, but we’re not fully buying the hype.”
Why the stock still bounced
The market mostly focused on the higher target and treated it like a green light, sending shares up about 6.3% intraday. That makes sense in a name like CoreWeave, where every little shift in Wall Street sentiment can feel like a meteorological event for the stock.
The bull case keeps getting louder
Bernstein isn’t alone in sounding more constructive. Other firms have recently upgraded or initiated coverage with chunky targets, while institutional holders like Vanguard have reportedly boosted positions. Add in marquee customer wins — including a reported Meta expansion and a new Anthropic partnership — and you’ve got the kind of revenue visibility that makes growth investors perk up.
But the warning label is still on the box
Here’s the part that keeps the party from turning into a parade:
- insiders have reportedly sold large blocks of stock recently
- the company remains unprofitable
- leverage is still heavy, with debt-to-equity around 4.46
So yes, the stock got a lift. But this is still a high-beta, high-expectation name where the next funding, contract, or margin update can matter a lot more than the average “upgrade” note.
Big picture: CoreWeave is getting more Wall Street attention and a higher valuation target, but the story is still equal parts AI rocket ship and balance-sheet balancing act.